Nonprofit · EIN 82-2120760
ODYLIA THERAPEUTICS INC
Tax-exempt · ATLANTA, GA 30316
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $1,523,364 | $1,406,969 | $116,395 | $1,741,781 | $921,012 | $820,769 |
| December 31, 2024 | 990 | $482,047 | $699,405 | -$217,358 | $1,594,795 | $907,239 | $687,556 |
| December 31, 2023 | 990 | $570,773 | $867,236 | -$296,463 | $9,688,644 | $41,336 | $9,647,308 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $898,455
- Program service revenue
- $609,083
- Investment income
- $15,826
- Net gain from sales of assets
- -$49,382
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $212,578
- Other salaries and wages
- $320,216
- Salaries, compensation and benefits (total)
- $611,716
- Professional fundraising fees
- $0
- Accounting fees
- $22,439
- Travel
- $3,639
- Program services (functional)
- $1,197,948
- Management and general (functional)
- $106,241
- Fundraising (functional)
- $102,780
Balance sheet and other
- Total assets, start of year
- $1,594,795
- Total assets, end of year
- $1,741,781
- Total liabilities, end of year
- $921,012
- Net assets, end of year
- $820,769
- Publicly traded securities
- $1,047,728
- Net assets without donor restrictions
- $820,769
- Gross receipts
- $2,090,096
- Employees
- 4
- Volunteers
- 8
- Year formed
- 2017
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ASHLEY WINSLOW | CEO/CSO Officer | 40 | $212,578 | $17,848 |
| JENNIFER KLEIN | MGR. OF OPERATIONS & PROG. MGMT. Highest-paid employee | 40 | $118,296 | $318 |
| KATHRYN POST PHD | DIRECTOR, BRYDGE SOLUTIONS Highest-paid employee | 40 | $105,324 | $269 |
| GREG ROBINSON | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| SCOTT DORFMAN | BOARD CHAIR Trustee or director, Officer | 3 | $0 | $0 |
| BRIAN FENTON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ELIZABETH ATTIAS | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| JOY CAVAGNARO | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| KHANDAN BARADARAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| MATTHEW PLETCHER | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| WENDY ERLER | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2024: 8 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ASHLEY WINSLOW | CEO/CSO Officer | 40 | $217,891 | $7,329 |
| JENNIFER KLEIN | MGR. OF OPERATIONS & PROG. MGMT. Highest-paid employee | 40 | $116,261 | $0 |
| SCOTT DORFMAN | BOARD CHAIR Trustee or director, Officer | 3 | $0 | $0 |
| ELIZABETH ATTIAS | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| KHANDAN BARADARAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| BRIAN FENTON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| MATTHEW PLETCHER | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| GREG ROBINSON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 9 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ASHLEY WINSLOW | CEO/CSO Officer | 40 | $230,695 |
| JENNY KLEIN | MANAGER OF OPERATIONS & PROGRAM MANAGEMENT Highest-paid employee | 40 | $109,099 |
| SCOTT DORFMAN | BOARD CHAIRMAN/TREASURER Trustee or director, Officer | 6 | $0 |
| SUSIE TROTOCHAUD | SECRETARY Trustee or director, Officer | 3 | $0 |
| KHANDAN BARADARAN | BOARD MEMBER Trustee or director | 1 | $0 |
| BRIAN FENTON | BOARD MEMBER Trustee or director | 1 | $0 |
| MATTHEW PLETCHER | BOARD MEMBER Trustee or director | 1 | $0 |
| LUK VANDENBERGH | BOARD MEMBER Trustee or director | 1 | $0 |
| GREG ROBINSON | BOARD MEMBER Trustee or director | 1 | $0 |
Address and contacts
- Address (IRS master file)
- 830 GLENWOOD AVE SE STE 510 PMB 32, ATLANTA, GA 30316-2176
- Mailing address (990-N for 2017)
- 209 Peachtree Circle, Atlanta GA 30309
- Principal officer (990 for 2025)
- ASHLEY WINSLOW, 830 GLENWOOD AVE SE 510-32, ATLANTA, GA 30316
- Principal officer (990-N for 2017)
- Scott Dorfman, 209 Peachtree Circle, Atlanta GA 30309
- Signed the 990
- ASHLEY WINSLOW, CEO/CSO
- Phone
- (404) 480-2994
- Website
- odylia.org
- Return prepared by
- MAULDIN & JENKINS LLC
Mission
ODYLIA UTILIZES A UNIQUE, NON-PROFIT MODEL TO DEVELOP AND ADVANCE THERAPEUTICS FOR PEOPLE WITH RARE DISEASES, CHANGING THE WAY TREATMENTS ARE BROUGHT FROM THE LAB TO THE CLINIC.
Program accomplishments
- ODYLIA'S TWO PRIMARY INITIATIVES ARE THE ODYLIA PIPELINE AND BRYDGE SOLUTIONS. THE PIPELINE INCLUDES THE RPGRIP1, USH1C, AND NPHP1 GENE THERAPY PROGRAMS. SIGNIFICANT ACCOMPLISHMENTS INCLUDED A SUCCESSFUL FDA PRE-IND MEETING AND PRECLINICAL DEVELOPMENT ACTIVITIES FOR THE RPGRIP1 PROGRAM, CLINICAL CANDIDATE SELECTION AND DELIVERY OPTIMIZATION FOR THE USH1C PROGRAM, AND INITIAL VECTOR DESIGN AND TESTING FOR THE NPHP1 PROGRAM. BRYDGE SOLUTIONS ACCELERATES THE DEVELOPMENT OF TREATMENTS FOR RARE DISEASES THROUGH STRATEGIC PARTNERSHIPS WITH PATIENT ADVOCACY ORGANIZATIONS, DISEASE FOUNDATIONS, AND RARE DISEASE FAMILIES. IN 2025, THE PROGRAM ESTABLISHED FIVE NEW PARTNERSHIPS WITH SAVE SIGHT NOW, MED13L FOUNDATION, UPSTREAM GENES, DLG4 SHINE SYNDROME FOUNDATION, AND PBD PROJECT.Expenses $1,197,948 · revenue $609,083
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 82-2120760
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2018
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H41)
- Assets (IRS master file)
- $1,741,781
- Income (IRS master file)
- $2,090,096
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $1,523,364 | $1,406,969 | $1,741,781 | XML |
| 990 | December 2024 | $482,047 | $699,405 | $1,594,795 | XML |
| 990 | December 2023 | $570,773 | $867,236 | $9,688,644 | XML |
| 990 | December 2022 | $1,098,401 | $866,473 | $10,021,651 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990-N for 2017 Officer: Scott Dorfman | December 31, 2017 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 82-2120760).
Questions about ODYLIA THERAPEUTICS INC
- What is the EIN of ODYLIA THERAPEUTICS INC?
- The employer identification number (EIN) of ODYLIA THERAPEUTICS INC is 82-2120760.
- Is ODYLIA THERAPEUTICS INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2018.
- Are donations to ODYLIA THERAPEUTICS INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does ODYLIA THERAPEUTICS INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of ODYLIA THERAPEUTICS INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did ODYLIA THERAPEUTICS INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of ODYLIA THERAPEUTICS INC?
- The 990 for the year ended December 31, 2025 names ASHLEY WINSLOW.
- Who are the officers and directors of ODYLIA THERAPEUTICS INC?
- The 990 for the year ended December 31, 2025 lists 11 people; 3 received compensation from the organization, the highest $212,578 (ASHLEY WINSLOW, CEO/CSO).
- How much revenue does ODYLIA THERAPEUTICS INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $1,523,364, expenses of $1,406,969 and total assets of $1,741,781 at year end.
Other nonprofits in ATLANTA
- RHEUMATOLOGY RESEARCH FOUNDATION EIN 58-1654301 · last filed 990 for 2025
- CURE CHILDHOOD CANCER INC EIN 58-1244138 · last filed 990 for 2025
- GEORGIA CENTER FOR ONCOLOGY RESEARCH AND EDUCATION INC EIN 57-1159979 · last filed 990 for 2025
- SOUTHERN LIGHT RAIL INC EIN 30-0240711 · last filed 990 for 2025
- EMPOWERMENT RESOURCE CENTER INC EIN 56-2587827 · last filed 990 for 2024
- EMTECH INC EIN 58-2585997 · last filed 990 for 2025
- ADEWUNMI DESALU PARKINSONS FOUNDATION INC EIN 92-2377265 · last filed 990 for 2025
- METABOLOMICS SOCIETY INC EIN 32-0107582 · last filed 990 for 2025